|
Market Research Report
Monoclonal Antibody Therapies: Sector Analysis Tool
| Published by |
Datamonitor |
| Published |
April, 2005 |
Product code |
29260 |
| Content info |
|
| Price |
|
|
This publication has been discontinued on July 19, 2011.
Introduction
The mAb Sector Analysis Tool presents the marketed and R&D portfolios, technology focus and product development strategies of over 100 key players in the mAbs market. In addition, you can to view, interrogate and tailor six-year sales forecasts for mAb products due to launch by 2010. This Sector Analysis Tool complements Monoclonal Antibody Therapies: Evolving into a $30 billion market (DMHC2069).
Key reasons to read this report
- Access data on the leading mAb products, technologies and players in the global pharmaceutical market analyzing current and future trends
- Compare players by global forecast therapy area sales and portfolio breakdown measures to identify winners and losers to 2010
- Drill down to individual drug forecasts and descriptions, identifying the key drivers behind forecast performance over the next six years
|
